Gain Therapeutics, Inc. (GANX) vs Heron Therapeutics, Inc. (HRTX)
A side-by-side comparison of Gain Therapeutics, Inc. and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GANX
Gain Therapeutics, Inc.
$1.74HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — GANX vs HRTX
growth of $100 · dividends reinvested · last 6yGANX -84.9% (-27.0%/yr)HRTX -97.6% (-46.4%/yr)GANX compounded faster over this window
Log scale — wide-divergence pair
GANX HRTX
GANX vs HRTX: by the numbers
- •GANX is the larger company ($74M vs $64M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -22.52% net margin).
Metrics side by side
Valuation
| Metric | GANX | HRTX |
|---|---|---|
| P/S ratio | N/A | 0.42 |
| P/B ratio | 6.55 | 10.91 |
Profitability
| Metric | GANX | HRTX |
|---|---|---|
| Gross margin | 0.00% | 70.07% |
| Operating margin | 0.00% | -7.19% |
| Net margin | 0.00% | -22.52% |
| ROE | -178.06% | -492.89% |
| ROIC | -159.24% | -6.79% |
Growth (annualized)
| Metric | GANX | HRTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.73% |
| Total return CAGR (5Y) | -25.06% | -48.61% |
Frequently asked
- How have GANX and HRTX total returns compared?
- Over the past 5 years, GANX delivered -25.06% and HRTX delivered -48.61% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.